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Background: It is well documented that osteoarthritis (OA) can develop following traumatic joint injury and is the
leading cause of lameness and subsequent wastage of equine athletes. Although much research of injury induced
OA has focused on cartilage, OA is a disease that affects the whole joint organ.
Methods: In this study, we investigated the impact of synovial cells on the progression of an OA phenotype in
injured articular cartilage. Injured and control cartilage were cultured in the presence of synoviocytes extracted
from normal equine synovium. Synoviocytes and cartilage were evaluated for catabolic and anabolic gene
expression. The cartilage was also evaluated histologically for loss of extracellular matrix molecules, chondrocyte cell
death and chondrocyte cluster formation.
Results: The results indicate synoviocytes exert both positive and negative effects on injured cartilage, but
ultimately protect injured cartilage from progressing toward an OA phenotype. Synoviocytes cultured in the
presence of injured cartilage had significantly reduced expression of aggrecanase 1 and 2 (ADAMTS4 and 5), but
also had increased expression of matrix metalloproteinase (MMP) -1 and reduced expression of tissue inhibitor of
metalloproteinases 1 (TIMP-1). Injured cartilage cultured with synoviocytes had increased expression of both
collagen type 2 and aggrecanase 2. Histologic examination of cartilage indicated that there was a protective effect
of synoviocytes on injured cartilage by reducing the incidence of both focal cell loss and chondrocyte cluster
formation, two major hallmarks of OA.
Conclusions: These results support the importance of evaluating more than one synovial joint tissue when
investigating injury induced OA.
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Osteoarthritis (OA) is the most common musculoskel-
etal disease in humans, and is the most common joint
disease in horses [1]. Although OA is not a disease that
exclusively affects the articular cartilage, the critical cri-
teria are the degradation and eventual loss of cartilage.
In addition to the articular cartilage the synovial mem-
brane, fibrous joint capsule and subchondral bone are
also compromised in an osteoarthritic joint. Synovial in-
flammation has been detected in both early and late
OA in humans [2-5] and in an equine in vivo study,
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reproduction in any medium, provided the orinstability, was sufficient to induce degradation of ar-
ticular cartilage [6]. The synovial fluid of injured or dis-
eased joints has been shown to contain anabolic and
catabolic cytokines such as prostaglandin E2 (PGE2),
Interleukin (IL) -1β, IL-6, IL-10, IL-1RA, tumor necro-
sis factor alpha (TNF-α), transforming growth factor
beta (TGFβ), and fibroblast growth factor 2 (FGF2), as
well as matrix degrading enzymes including aggreca-
nases (ADAMTS4 and 5), and matrix metalloproteinase
(MMP) MMP-1 [7-11]. Both Il-1 and TNF-α have also
been shown to induce chondrocyte expression of
MMPs by an autocrine/paracrine mechanism [12] and
promote enhanced proteoglycan loss in injured cartilage
samples [13]. It has even been suggested that synovial
inflammation may promote altered chondrocyte gene. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Fibroblastic synoviocyte phenotype. Digital Image of
synoviocytes harvested from a horse and expanded to passage 3.
Image obtained at 10x magnification.
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matrix (ECM) destruction [14,15].
Although previous studies investigating the relation-
ship between the synovium and cartilage are limited,
intercellular interactions have been identified where
synovial cells and chondrocytes communicate by direct
contact [16] or indirectly by synovial cell release of mo-
lecular agents [17]. Additionally, the presence of syn-
ovial tissue has been shown to alter the progression of
IL-1β induced OA in cartilage explants in vitro [18]
and to inhibit cartilage biosynthesis in cartilage explants
by an IL-1 independent pathway [19], both suggesting
that the progression of ECM degradation and OA is
dependent on both the cartilage and the synovium. In a
more recent in vitro model the co-culture of injured
cartilage with joint capsule explants enhanced the dele-
terious effects of injury on catabolic gene expression in
cartilage and resulted in a reduction of cartilage aggre-
can content [20]. Therefore in this study we sought to
investigate how co-culture of cartilage and synovial cells
(synoviocytes) affects chondrocyte and synoviocyte gene
expression profiles as well as cartilage pathology after
cartilage injury. In this article we demonstrate that the
culture of synoviocytes in the presence of injured cartil-
age reduces the presence of markers of early OA in car-
tilage such as focal cell loss and chondrocyte cluster
formation, and alters chondrocyte gene expression to
favor anabolic activity.
Methods
Isolation of cartilage plugs
Equine cartilage samples were extracted from cadaveric
stifle joints within sixteen hours of death from 12 differ-
ent horses (ages 3–5 years) that died for reasons unre-
lated to the musculoskeletal system and factors not
influencing this study. Using aseptic technique (sterile
gloves, instruments and media) osteochondral plugs
5 mm in diameter (varying heights) were harvested from
the trochlear ridges of the left and right limbs using a
customized cylindrical osteotome (Sontec Instruments,
Centennial CO). Due to the non-uniform swelling of the
cartilage that occurs during culture when the cartilage
remains attached to the subchondral bone, the cartilage
was removed from the subchondral bone at the calcified
and non-calcified cartilage junction immediately after
extraction from the joint. To allow for recovery of the
chondrocytes from tissue harvest the explants were cul-
tured for forty-eight hours in full growth medium
(DMEM (Invitrogen, Carlsbad, CA), 10% fetal bovine
serum (v/v) (Hyclone, Logan, UT), 20 μg/ml ascorbic
acid (Sigma Aldrich, St Louis, MO), 1% penicillin and
streptomycin (v/v) (Invitrogen, Carlsbad, CA), 10 mM
HEPES (Invitrogen, Carlsbad, CA), 0.1 mM non-essential
amino acids (Invitrogen, Carlsbad, CA), 0.4 mM proline(Sigma Aldrich, St Louis, MO), 0.25 μg/ml amphotericin
B (Invitrogen, Carlsbad, CA)) prior to commencement of
the experiments.
Synoviocyte isolation
Synoviocytes were isolated from synovial tissue har-
vested from the stifle of 6 different horses than those
used for cartilage harvest (ages 3–5) that also died for
reasons unrelated to the musculoskeletal system and to
this study. Synovial tissue was minced and incubated
with media containing collagenase type II (Worthington
Biochemical, Lakewood, NJ) in a spin column flask for
4 hours. Synoviocytes were then filtered from the media
using a 40 μm filter and culture expanded in full growth
medium (Ham’s F12(Invitrogen, Carlsbad, CA), 10% FBS
(v/v) (Hyclone, Logan, UT), 1% antibiotic and antimyco-
tic (v/v) (Invitrogen, Carlsbad, CA) and 10 mM HEPES
(Invitrogen, Carlsbad, CA)) to passage 3 to ensure >95%
of the cells will express a fibroblastic phenotype (Figure 1)
[21] with minimal presence of lymphocytes, natural killer
cells and macrophages [22] followed by cryopreservation
until experiment commencement.
Mechanical injury
Just prior to injury, the thickness of each cartilage plug
(plane perpendicular to the articular surface; average
thickness 1.33 mm) was measured using digital calipers.
Cartilage plugs were injured as previously defined [23].
In brief, cartilage plugs were removed from media and
placed into a sterile polysulphone loading chamber con-
sisting of a well aligned coaxially with an impermeable
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a H1KS benchtop universal testing machine (Tinius
Olsen, Horcham PA) an initial compressive tare load of
4 N was applied. After creep equilibrium was attained
for 5 seconds, an injurious compression at a rate of
100% strain/second was applied until 60% final cartilage
strain was achieved. Compression was then released at
the same rate and plugs were immediately placed into
the appropriate culture condition.
Cartilage-synoviocyte co-culture
Synoviocyte and cartilage were co-cultured using a trans-
well plate with a 0.4 μm microporous insert (Corning
Inc., Corning, NY). Cartilage and synoviocytes were ran-
domly paired for co-culture to form 2 sets of experi-
ments. One set of experiments involved the culture of
synoviocytes with cartilage for gene expression analysis
at 1, 2, 4 and 8 days in co-culture. The other set of
experiments involved the culture of synoviocytes with
cartilage for histologic and immunologic evaluation at
days 8, 16 or 32 in culture. The time points to evaluate
gene expression were determined based on previous
studies that have evaluated changes in gene expression in
cartilage after injury [18,20]. For histologic evaluation we
extended the duration of culture because in previous
studies [23] we found injured cartilage required culture
for at least 28 days to develop histologic changes. Each
experiment was conducted in duplicate, and all experi-
ments repeated a total of 6 times using cartilage from a
new horse for each experiment and synoviocytes from 6
different horses total; synoviocytes from each horse were
used for one gene expression and one histology experi-
ment. Each experiment consisted of four conditions;
injured and control (uninjured) cartilage cultured alone
or with synoviocytes. Experiments for gene expression
analysis included the fifth condition of synoviocytes cul-
tured alone. Forty-eight hours prior to commencement
of experiment synoviocytes were recovered from liquid
nitrogen and seeded into the bottom well of a 24-well
transwell system at a seeding density of 5000 cells/cm2
and cultured in growth media composed of half cartilage
DMEM media and half synoviocyte F12 media. Immedi-
ately after injury, cartilage plugs were added to the top
well of the transwell system, uninjured control cartilage
samples were maintained in parallel. All samples
remained in culture for 1, 2, 4, 8, 16 or 32 days, with
media changes every 2–3 days.
Sample collection
For gene expression analysis, cartilage and synoviocytes
were removed from incubation at 1, 2, 4 and 8 days
and immediately placed on ice. The cartilage plugs
were rinsed with ice cold RNase free PBS then snap
frozen in Trizol (Invitrogen, Carlsbad, CA) and storedat −80°C. Similarly the synoviocytes were rinsed with
ice cold RNase free PBS, treated with 350 ul of RLT
lysis buffer (RNeasy minikit, Qiagen, Valencia CA) and
stored in −80°C. For histology and immunohistochemis-
try (IHC) cartilage samples at days 8, 16 and 32 were
removed from culture and sectioned across the diameter
perpendicular to the fissures when present (arbitrarily in
the middle of the sample when not) and always along a
plane perpendicular to the superficial surface. One half
of each sample was placed into 10% neutral buffered for-
malin for histologic analysis and the remaining half was
embedded in OCT, snap frozen in liquid nitrogen and
stored at −80°C for immunohistochemistry.
RNA extraction
To extract RNA from synoviocytes, samples in RLT lysis
buffer were thawed and passed through a QIAshredder
homogenization column (Qiagen, Valencia, CA) followed
by RNA extraction using the RNeasy Mini Kit (Qiagen,
Valencia, CA) according to the manufacturer’s instruc-
tions with on column genomic DNA digest using RNase
free DNase (Qiagen, Valencia, CA). To extract RNA
from cartilage, the plugs were pulverized and homoge-
nized in Trizol (Invitrogen, Carlsbad, CA) on ice using a
tissue homogenizer. The homogenized sample was then
allowed to incubate at room temperature for 20 minutes
in Trizol followed by centrifugation at 12,000 x g for
12 minutes at 4°C. The supernatant was transferred to a
new microcentrifuge tube, mixed with 400 ul chloro-
form, incubated at room temperature for 3 minutes and
then centrifuged at 12,000 × g for 15 minutes at 4°C.
The aqueous phase was transferred to a new microcen-
trifuge tube, mixed with 200 ul chloroform, incubated at
room temperature for 3 minutes then centrifuged at
12,000 × g for 15 minutes at 4°C. The aqueous phase
was transferred to a new microcentrifuge tube to which
500 ul isopropanol was added. The samples were incu-
bated at room temperature for 10 minutes then centri-
fuged at 12,000 × g for 10 minutes at 4°C to pellet
the RNA. The RNA fraction was cleaned with 70%
ethanol and re-suspended with RNase free water fol-
lowed by digestion of genomic DNA using RNase free
DNase (Qiagen, Valencia, CA).
Real time PCR
Synoviocyte mRNA was evaluated for expression of cycloox-
ygenase 2 (cox-2), interleukin 1β, 6, 10 (IL-1β, -6, -10),
interleukin 1 receptor antagonist protein (IRAP),
matrix metalloproteinase 1, 3, 13 (MMP-1,-3,-13),
transforming growth factor β (TGF-β), tissue inhi-
bitor of metalloproteinases 1 (TIMP-1), aggrecanase
1, 2 (ADAMTS4, 5) and fibroblast growth factor 2
(FGF2). Chondrocyte mRNA was evaluated for collagen
types 1 and 2 (Col1 and Col2), aggrecan, IL-1β, -6, -10,
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TIMP-1. All expression levels were normalized to gly-
ceraldehyde 3-phosphate dehydrogenase (GAPDH) as
screening of all samples determined no variability in
GAPDH expression. Equal concentrations of RNA
(5 ng) from each sample were reverse transcribed
into cDNA using superscript First-Strand Synthesis
for RT-PCR (Invitrogen, Carlsbad, CA). Relative gene
expression levels were determined by semi-quantitative
real time PCR using TaqMan based probes and primers
purchased from the Lucy Whittier Molecular and Diag-
nostic core facility at University of California, Davis, or
from the Orthopaedic Research Center at Colorado
State University, Fort Collins (Table 1). All real time
PCR assays were run on the ABI Prism 7000 Sequence
Detection System (Applied Biosystems, Forster City,
CA). Relative gene expression (using the delta delta Ct
method [24]) was determined by comparing gene ex-
pression levels to baseline, where baseline for synovio-
cytes is equal to expression in synoviocytes cultured
alone, and for injured cartilage cultured alone or in co-
culture baseline is equal to control cartilage cultured
alone or in co-culture respectively.
Histology
Formalin fixed samples were paraffin embedded, and
sectioned (5 μm thick) using a Leica RM2255 microtome
(Leica Biosystems, Buffalo Grove IL). One slide each
from an injured and control sample was stained with
Hematoxylin and Eosin (H&E) to evaluate cellular patho-
logic changes or Safranin O Fast Green (SOFG) to detect
changes in regional glycosaminoglycan (GAG) content. All
images of slides were obtained using Q-capture (QImaging,
Surrey BC).
Immunohistochemistry (IHC)
Immunohistochemical staining was conducted for the de-
tection of aggrecan and collagen type II. Briefly, frozen em-
bedded samples were sectioned (8 μm thick) and mounted
onto adhesive slides using the CryoJaneW Tape-Transfer
system (Instrumedics Inc., St Louis, MO). Sections were
probed with mouse antibodies raised against aggrecan at a
1:20 dilution (Novus Biologics, Littleton, CO) or collagen
type II using undiluted supernatant (Hybridoma Bank,Table 1 Table of primer and probe sequences from the Ortho
Gene Forward Reverse
IL-1B AGTCTTCAGTGCTCAGGTTTCTGA TGCCGC
IL-10 TTCAGCAGGGTGAAGACTTTC CTTGGC
TGF-B GTTAAGCGTGGAGCAGCAT AGTGAC
ADAMTS4 TGTGATCGTGTCATTGGCTCC TGTTTGC
ADAMTS5 AAGGTGACTGATGGGACCGAATGT TTTGAGIowa City, IA), followed by probing with a goat anti mouse
secondary antibody conjugated with horseradish peroxid-
ase at a 1:500 dilution (Jackson Immunoresearch West
Grove, PA) and antibody detection with VECTORW
NovaRED™ (Vector laboratories, Burlingame, CA). For
negative controls, additional sections were probed with
normal mouse serum at a concentration equal to that of
the primary antibody.
Section grading
All histological and IHC sections were blindly evaluated
using a previously established grading scale detailing the
severity of OA characteristics in equine cartilage [25]. In
brief, each region was assigned a grade for each OA
characteristic that corresponds to the severity by which
the sample deviates in histologic appearance compared
to normal articular cartilage where 0 = normal or no
change, 1 = slight, 2 =mild, 3 =moderate. To eliminate
the inclusion or artifact from tissue harvest in the ana-
lysis, the outer 5% of the tissue around the left and right
edges and below the deep zone were not graded. One
section was graded for each sample. For each OA char-
acteristic, scores for each region (superficial, middle,
deep and fissures) were evaluated separately then
summed together for each slide, the maximum score for
each of the 4 regions was 3 creating a maximum score
for all regions combined of 12. Sections stained with
H&E were used to visualize generalized chondrocyte cell
death (determined by the amount of lacunae lacking dis-
cernable nuclei), localized cell death/focal cell loss (the
presence of distinct regions devoid of discernable nuclei)
and chondrocyte cluster formation (lacunae containing
more than one nuclei). Changes to the ECM were deter-
mined using both histologic and IHC stained sections.
Safranin O Fast Green stained sections were used to
identify proteoglycan content of control and treated car-
tilage. To identify ECM molecules more specifically, sec-
tions stained by IHC were used to assess regions
containing aggrecan and collagen type II in control and
treated cartilage.
Statistical analysis
Statistical analysis was conducted to determine differ-
ences in IHC and histologic staining results accountingpaedic Research Center
c TaqMan probe
TGCAGTAAGTCATC CAGCCATGGCAGCAGTACCCGA
AACCCAGGTAACCCTTA TGTTGAACGGGTCCCTGCTGGAG
ATCAAAGGACAGCC CTGCTGACCCCCAGCGACTCG
TGCAGCTAGAACCATC AGTTTGACAAGTGCATGGTGTGCGGT
CCAATGATGCCGTCACAG AGGCCATACAGTAATTCCGTCTGCGT
Figure 2 (See legend on next page.)
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Figure 2 Synoviocyte gene expression. (A) Gene expression data for synoviocytes in the presence of injured or control cartilage. Data
presented as mean relative expression across all time points for each culture condition (± SEM) * denotes statistically significant difference
between pairs, + denotes statistically significant difference from baseline, p-value < 0.05. (B) MMP-1 expression was significantly affected by both
treatment and duration in culture with a significant increase in expression in synoviocytes cultured with injured cartilage after 48 hours.
Synoviocyte gene expression levels are relative to synoviocytes cultured alone. Bars represent mean (± SEM), bars with the same letter for each
pathology are not significantly different from each other, significance set at alpha (p-value) = 0.05, n = 6. Main effects or interactions were
evaluated in the AOV table with a predictive F-value (Pr > F).
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dictive F-values were used to determine statistical differ-
ences between injury and control or between regions,
with specific comparisons made using a least squares
means procedure, both with significance set at α = 0.05.
Results
Gene expression
In synoviocyte samples, mRNA expression of IL-1β,
IL-1RA, IL-10 and TNF-α was not detected. There
were no significant differences in the expression of
cox-2, MMP-3,-13, IL-6, FGF2 and TGFB in synovio-
cytes cultured with control versus injured cartilage
samples (Figure 2A). Synoviocyte expression of
MMP-1 (p = 0.0334), ADAMTS4 and 5 (p = 0.0004
and p = 0.0011), and TIMP-1 (p = 0.0010) were sig-
nificantly affected by culture condition. Synoviocytes
cultured in the presence of control cartilage had a sig-
nificantly higher relative expression of ADAMTS4 and
5 (p < 0.0001 and p = 0.0005) and TIMP-1 (P = 0.0007)
compared to synoviocytes cultured with injured cartil-
age (Figure 2A). Synoviocytes cultured with injured
cartilage had significantly higher expression of MMP-1
(p = 0.0095) and significantly lower expression of
ADAMTS4 and 5 (p = 0.007 and p = 0.0037) and TIMP-1
(p = 0.0022) compared to baseline synoviocyte culture
(Figure 2A). Expression of MMP-1 in synoviocytes
was significantly affected by both main effects treat-
ment and duration in culture where synoviocytes cul-
tured in the presence of injured cartilage had
significantly greater expression at two days in culture
compared to synoviocytes cultured with injured car-
tilage (p = 0.0339) including baseline (synoviocytes
cultured alone) (p < 0.0001) (Figure 2B).
In cartilage samples we were unable to detect mRNA
expression of IL-1β, IL-1RA, IL-10, TNF-α, FGF2 or
Col1, and there were no significant differences in ex-
pression levels of MMP-1, -3, -13, ADAMTS4, TGFβ
and IL-6 between cartilage treatments or compared to
baseline (Figure 3A). Injured cartilage co-cultured with
synoviocytes had significantly higher expression of colla-
gen type 2 (p = 0.0027) and ADAMTS5 (p = 0.0401) com-
pared to injured cartilage cultured alone (Figure 3A) and
had significantly higher expression of type 2 collagen
(p <0.0001) and cox-2 (p = 0.0283) compared to controlcartilage cultured with synoviocytes (Figure 3A). Injured
cartilage cultured alone had significantly higher expression
of aggrecan compared to control cartilage (p = 0.0371)
(Figure 3A). TGF-β levels were significantly highest in
injured cartilage cultured in the presence of synoviocytes
at day two compared to all other injured cartilage samples
(p <0.0001) and control cartilage cultured with synovio-
cytes (p <0.0001) (Figure 3B).
Histologic evaluation
Histologic sections stained with H&E showed increased
chondrocyte cell death in injured cartilage cultured with
or without synoviocytes compared to both uninjured
controls (p < 0.0001). There was no significant difference
in generalized cell death between injured cartilage sam-
ples cultured with and without synoviocytes (Figure 4A).
Independent of treatment, the incidence of cell death in
all cartilage samples was significantly increased at day 32
compared to days 8 and 16 (p < 0.0001) (Figure 4B).
Injured cartilage cultured alone had a significantly higher
incidence of focal cell loss at day 16 and 32 compared to
all other treatment groups (p = 0.0258) (Figure 4C).
Chondrocyte cluster formation was significantly more se-
vere in injured cartilage cultured alone compared to all
other treatments (p < 0.0001) (Figure 5A). The size of
chondrocyte clusters (based on number of nuclei) was
significantly affected by both treatment and duration in
culture. Chondrocyte clusters in the injured cartilage cul-
tured alone were significantly larger at days 16 and 32
compared to the clusters formed in any other treatment
(p = 0.0130) (Figure 5B, C).
Sections stained with SOFG revealed effects of both
treatment and duration in culture (p = 0.0058) (Figure 6A).
At day 8, there was a significant reduction in total SOFG
staining in all treatment groups compared to control car-
tilage cultured alone (Figure 6A). At day 16 there was a
trend of reduced SOFG staining in samples cultured in
the presence of synoviocytes, and at day 32 there was no
significant difference in SOFG staining between any treat-
ment (Figure 6A).
The results from IHC staining show no significant
differences in aggrecan content between any samples
(Figure 7). Immunohistochemical staining for collagen
type II content indicate collagen was not affected by
treatment, however duration in culture had a significant
Figure 3 (See legend on next page.)
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Figure 3 Chondrocyte gene expression. (A) Gene expression data for injured cartilage cultured alone or with synoviocytes. Data presented as
mean relative expression across all time points for each culture condition (± SEM) * denotes statistically significant difference between pairs, +
denotes statistically significant difference from baseline p-value < 0.05. (B) TGF-β expression was significantly affected by both treatment and
duration in culture with a significant increase in expression in synoviocytes cultured with injured cartilage after 48 hours. Chondrocyte gene
expression levels for injured cartilage are relative to expression of uninjured cartilage. Bars represent mean (± SEM), bars with the same letter for
each pathology are not significantly different from each other, significance set at alpha (p-value) = 0.05, n = 6. Main effects or interactions were
evaluated in the AOV table with a predictive F-value (Pr > F).
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tion compared to all other treatment groups (p = 0.0460)
(Figure 6B).
A summary of all histology and immunohistologic
changes can be seen in Figure 7.
Discussion
Injury induced OA is a disorder affecting multiple
organs of the synovial joint, yet many in vitro models to
study injury induced OA only examine the cartilage. In
this study, we sought to develop a co-culture model of
injured cartilage and synoviocytes to determine if andFigure 4 Chondrocyte cell death and focal cell loss. (A) Chondrocyte c
the presence of synoviocytes and (B) independently of treatment was sign
Focal cell loss was significantly affected by both treatment and days in cult
greatest severity at 16 and 32 days compared to the other treatments. Bars
are not significantly different from each other, significance set at alpha (p-v
table with a predictive F-value (Pr > F), n = 6.how synoviocytes modulate the progression of an osteo-
arthritic phenotype in injured cartilage. The data pre-
sented here indicate that normal synoviocytes protect
cartilage from the effects of injury by reducing aggreca-
nase gene expression, promoting collagen type 2 expres-
sion and reducing the incidence of injury induced focal
cell loss and chondrocyte cluster formation.
The aggrecanases ADAMTS4 and 5 are the enzymes
that are largely responsible for degrading aggrecan under
pathologic conditions [26,27]. In this study when syno-
viocytes were cultured in the presence of injured cartil-
age there was a significant reduction in synoviocyteell death was significantly increased in injured cartilage regardless of
ificantly increased at day 32 compared to the earlier time points. (C)
ure with injured cartilage not in the presence of synoviocytes have the
represent mean (± SEM), bars with the same letter for each pathology
alue) = 0.05. Main effects or interactions were evaluated in the AOV
Figure 5 Chondrocyte cluster formation. (A) The severity of chondrocyte cluster formation was significantly higher in the injured cartilage
cultured in the absence of synoviocytes compared to all other treatments. (B) The size of chondrocyte clusters was significantly affected by both
treatment and duration in culture; injured cartilage samples cultured alone had significantly larger chondrocyte clusters at days 16 and 32
compared to samples in other treatment groups. Bars represent mean (± SEM), bars with the same letter for each pathology are not significantly
different from each other, significance set at alpha (p-value) = 0.05. Main effects or interactions were evaluated in the AOV table with a predictive
F-value (Pr > F). (C) Representative H&E sections showing differences in chondrocyte cluster formation. Picture oriented with superficial surface on
top and deep zone on bottom. Arrows indicate chondrocyte clusters, n = 6.
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suggest these cells respond to injured cartilage by down
regulating catabolic activity. Matrix metalloproteinases
are the endopeptidases that are primarily responsible for
the degradation of collagens, while tissue inhibitor of
metalloproteases inhibit MMP activity. Under normal
conditions, MMPs and TIMPs exist in a state of dynamic
equilibrium [28]. This balance is shifted under pathologic
conditions to favor MMP expression and activity ultim-
ately contributing to ECM degradation [9,29-33]. Syn-
ovial fluid from injured and osteoarthritic joints has been
shown to contain high levels of MMP-1[34,35]. Contrary
to the anabolic response of aggrecanase down regulation
by synoviocytes in our study, we found an increased
synoviocyte expression of MMP-1 when cultured in the
presence of injured cartilage that was accompanied by a
decrease in TIMP-1 expression which together suggests
an increased catabolic activity by synoviocytes. Given
that aggrecan is the major target molecule for ECMdegradation, and that ADAMTS enzymes are more effi-
cient at cleaving aggrecan then MMPs [36], it is possible
that the down regulation of ADAMTS4 and 5 by syno-
viocytes may have a greater impact on cartilage degrad-
ation then the increased MMP-1 expression.
Although it is accepted that synovitis contributes to
cartilage degradation and OA, we were unable to de-
tect many of the putative pro-inflammatory cytokines,
and the expression levels of those present in our study
such as cox-2, TGFβ, IL-6 and FGF2 were unaffected
by culture with cartilage. We were unable to detect
IL-1β, IL-1RA, IL-10 or TNF-α mRNA in the synovio-
cytes via real time PCR. This could be explained by
our synovial cell extraction and culture conditions
favoring a more pure population of fibroblastic syno-
viocytes rather than synovial macrophages or that we
used normal, un-inflamed synovial membrane. Synovial
macrophages have been shown to have an important
role in promoting inflammation as well as stimulating
Figure 6 Changes in extracellular matrix composition determined by histology and IHC. (A) Total proteoglycan content was significantly
affected by both treatment and duration in culture. (B) Independent of treatment, collagen type II content was significantly affected by duration
in culture and was significantly reduced at day 32 compared to day 8. Bars represent mean (± SEM), bars with the same letter for each pathology
are not significantly different from each other, significance set at alpha (p-value) = 0.05, n = 6. Main effects or interactions were evaluated in the
AOV table with a predictive F-value (Pr > F).
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[37]. Indeed in a study where macrophages were depleted
from the population of cells digested from synovium
explants, there was a significant reduction in the expres-
sion of inflammatory cytokines including IL-1 and MMPs
[37]. Thus, the lack of IL-1β and TNF-α detection in the
present study likely reflects the difference between using
a purified population of fibroblastic synovial cells instead
of synovium explants.
Interleukin -1β and MMP-13 have both been exten-
sively demonstrated to play a prominent role in the
progression of OA yet IL-1β gene expression by chon-
drocytes was not detected in the present study and
MMP-13 expression levels were not affected by injury
or culture condition. Interestingly this finding is consist-
ent with a recent study conducted by Ross et al. 2012involving an in vivo model of experimentally induced
synovitis in the horse [38]. In the in vivo study the data
strongly demonstrated the development of a model con-
sistent with traumatic arthritis and OA, yet IL-1β gene
expression levels were not consistently detectible and
MMP-13 expression did not differ between normal and
inflamed joints. These results collectively suggest IL-1β
and MMP-13 gene expression may not be a critical com-
ponent of traumatic joint injury in horses.
The differential expression of type 2 collagen and
ADAMTS5 observed in injured cartilage cultured in the
presence of synoviocytes compared to injured cartilage
cultured alone further suggests a relationship exists be-
tween synoviocytes and injured cartilage. Type 2 colla-
gen expression was the highest in injured cartilage when
cultured in the presence of synoviocytes compared to
Figure 7 Representative images of cartilage samples in each culture condition after 32 days in culture. Images represent slides stained
with SOFG and H&E or by immunohistochemistry to detect collagen type II and aggrecan. Box inserted into the images showing collagen type II
and aggrecan show the negative control slides.
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ing suggests the presence of synoviocytes induces an
anabolic response by chondrocytes that is specific to
injured cartilage, as this increase was not seen in con-
trol cartilage cultured with synoviocytes. On the con-
trary, ADAMTS5 expression by chondrocytes of injured
cartilage cultured in the presence of synoviocytes was
higher than by chondrocytes of injured cartilage cul-
tured alone. Again this effect of synoviocytes appears to
be unique to injured cartilage as this increased expres-
sion was not observed in chondrocytes of cartilage in
any other condition. In a similar study conducted by
one of the co-authors (AJG), the culture of injured car-
tilage in the presence of synovium explants had a simi-
lar effect on chondrocyte gene expression [20]. In that
Lee et al. study [20] the introduction of synovium
explants to injured cartilage increased the expression of
ADAMTS5 at the early time points after injury and the
expression of ADAMTS4 was significantly increased for
the duration of the experiment. In the Lee et al. study
[20] study expression of type 2 collagen was not
affected by the presence of synovium explants, as it wasin the present study. Again, the results in the present
study may highlight a response that is specific to the
population of synovial fibroblasts that is lost when
fibroblasts are grouped together with other synovial
cells in the synovium.
The presence of synoviocytes also significantly
increased TGFβ expression in injured cartilage at two
days in culture when compared to any other time point
or condition including baseline. Transforming growth
factor β is an anabolic factor that induces chondrocyte
synthesis of ECM molecules by mesenchymal stem cells
and chondrocytes [39,40] and leads to increased chon-
drocyte proliferation [41]. Although the results seem
contradictory, it is not uncommon for chondrocytes to
express both anabolic and catabolic genes at one time,
and may reflect an attempt of chondrocytes at cartilage
repair and remodeling. In a study that tested repair tissue
in an equine cartilage defect model, both normal and re-
pair cartilage tested positive for the expression of genes
associated with matrix synthesis and degradation [42].
Evaluating the gene expression data together the over-
all impact of synoviocytes on injured cartilage indicates
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in chondrocytes potentially to protect from typical deg-
radation in response to injury.
Synoviocytes also had an impact on histologic changes
in injured cartilage. Cartilage injury and OA have been
associated with ECM degradation and ECM molecule
loss [43-46]. In the present co-culture samples, we show
that over time for all cartilage samples there was a
steady decrease in SOFG staining which was used as a
semi-quantitative evaluation of GAG content. Analysis
of aggrecan content by IHC showed no significant dif-
ferences between samples. In all samples there was a
gradual reduction in type II collagen for the duration
of the experiment resulting in a significant reduction
at day thirty-two compared to day eight. Given this re-
duction occurred in all samples, one can assume it is
likely an artifact of maintaining cartilage in static cul-
ture for thirty-two days. Taken together these data in-
dicate the presence of synoviocytes did not impact
ECM morphology.
Chondrocyte cell death is a typical result of cartilage
injury and can contribute to the subsequent degradation
of the ECM independent of mechanical trauma [47].
Chondrocyte cell death will occur either by necrosis or
apoptosis (chondropoptosis). With necrosis the cells will
swell and ultimately lyse. With apoptosis, the chondro-
cytes undergo programmed cell death which typically
leads to the unique event of chondroptosis where autop-
hagic vacuoles develop and digest the remaining cell
fragments leaving an empty lacunae [48]. Cell death is
believed to be an important consequence of injury con-
tributing to pathologic changes in cartilage, such that
hypocellularity and empty lacunae are parameters used
to characterize osteoarthritic cartilage [49-51]. In these
studies cell death was assessed by the two morphological
parameters; first by identifying empty lacuna, and second
by assessing focal regions with empty lacunae. In these
experiments cell death was affected by duration in cul-
ture with the greatest incidence at thirty-two days in cul-
ture regardless of treatment. Additionally, all injured
cartilage samples had a significantly greater incidence of
cell death and focal cell loss when compared to control
cartilage, and the increase in focal cell loss was signifi-
cantly reduced in injured cartilage cultured with syno-
viocytes. The data presented here suggest synoviocytes
protect injured cartilage from focal cell loss, a result that
has not previously been reported in the literature.
As would be expected, chondrocyte clusters were
detected in cartilage after injury [52,53]; however, when
injured cartilage was cultured in the presence of syno-
viocytes, chondrocyte cluster formation was significantly
reduced to a level that was no different than control car-
tilage. Furthermore, when injured cartilage was cultured
in the presence of synoviocytes, chondrocyte cluster sizewas significantly smaller. Clusters have been shown to
express markers of hypertrophy such as type X collagen
[54], alkaline phosphatase [55] and osteocalcin [56], the
matrix molecule fibronectin [57], and ECM degrading
enzymes [58]. Synoviocytes appear to affect cluster for-
mation and reduce the severity of this OA characteristic
of cartilage in response to injury, which may have a sig-
nificant impact on the progression of disease after injury.
Conclusions
In summary, the data presented in this study collect-
ively indicate that normal synoviocytes protect cartilage
from the effects of cartilage injury, and reduce the
progression of an OA phenotype. These data are con-
sistent with a similar co-culture model of cartilage
explants and synoviocytes [18]. Although it is widely
accepted that the synovium releases pro-inflammatory
molecules in response to joint injury, the data pre-
sented here indicate the catabolic effects of the syno-
vium may not come from the fibroblastic synoviocytes
and instead from other cells that make up the syno-
vium such as macrophages, or alternatively inflamed
synovial membrane has totally different characteristics
than normal synovial membrane. Furthermore, the iso-
lation and culture of the synoviocytes in this study is
quite similar if not the same as that of isolating and
expanding synovial derived stem cells [59,60]. In future
studies, we will isolate synovial derived stem cells from
the synovium to determine if those cells emulate the
beneficial effects of synoviocytes in the present study.
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